About the Company
We do not have any company description for Scilex Holding Co at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Scilex Holding Co
Scilex CEO to resign as focus turns to Semnur – Denali merger
Scilex Holding (NASDAQ:SCLX) announced on Thursday that its CEO, Jaisim Shah, would resign and continue to lead its ...
Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”), and Denali Capital Acquisition Corp. Have Entered ...
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and ...
Scilex Subsidiary Semnur Pharma Eyes $20M Private Placement Deal: More Details Inside
Scilex Holding Company (SCLX) on Thursday said that its majority-owned subsidiary, Semnur Pharmaceuticals, and Denali Capital Acquisition Corp (DECA) have entered into a purchase agreement with an ...
Scilex Holding Company Announces Deferral of Preferred Stock ... - Nasdaq
Scilex Holding Company announced that its Board of Directors has decided to defer the record date for a previously announced preferred stock dividend, originally set for May 2, 2025, to a later ...
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Provides Certain Preliminary Unaudited Financial ...
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Announces Early Repayment of $13.2 ... - Nasdaq
Scilex Holding Company, based in Palo Alto, California, has announced a voluntary early installment payment of $13.2 million towards its senior secured promissory note issued to Oramed ...
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic ...
Scilex Holding Company Chief Executive Officer and President ... - KRON4
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Scilex Holding Company Announces Signing of a $50 Million Registered ...
SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned.
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ...
Contacts: Investors and Media Scilex Holding Company 960 San Antonio Road Palo Alto, CA 94303 Office: (650) 516-4310 Email: investorrelations@scilexholding.com Website: www.scilexholding.com ...
Similar Companies
Loading the latest forecasts...